Girmenia, Corrado; Cavo, Michele; Offidani, Massimo; Scaglione, Francesco; Corso, Alessandro; Di Raimondo, Francesco; Musto, Pellegrino; Petrucci, Maria Teresa; Barosi, Giovanni, Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations, «BLOOD REVIEWS», 2019, 34, pp. 84 - 94 [articolo]
Bavaro, Luana; Martelli, Margherita; Cavo, Michele; Soverini, Simona, Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2019, 20, pp. 6141 - 6164 [articolo]Open Access
Gambella, Manuela; Omedé, Paola; Spada, Stefano; Muccio, Vittorio Emanuele; Gilestro, Milena; Saraci, Elona; Grammatico, Sara; Larocca, Alessandra; Conticello, Concetta; Bernardini, Annalisa; Gamberi, Barbara; Troia, Rossella; Liberati, Anna Marina; Offidani, Massimo; Rocci, Alberto; Palumbo, Antonio; Cavo, Michele; Sonneveld, Pieter; Boccadoro, Mario; Oliva, Stefania, Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis, «CANCER», 2019, 125, pp. 750 - 760 [articolo]
Bringhen, Sara; Mina, Roberto; Petrucci, Maria Teresa; Gaidano, Gianluca; Ballanti, Stelvio; Musto, Pellegrino; Offidani, Massimo; Spada, Stefano; Benevolo, Giulia; Ponticelli, Elena; Galieni, Piero; Cavo, Michele; Di Toritto, Tommaso Caravita; Di Raimondo, Francesco; Montefusco, Vittorio; Palumbo, Antonio; Boccadoro, Mario; Larocca, Alessandra, Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies, «HAEMATOLOGICA», 2019, 104, pp. 1640 - 1647 [articolo]Open Access
Dimopoulos MA1, Gay F2, Schjesvold F3, Beksac M4, Hajek R5, Weisel KC6, Goldschmidt H7, Maisnar V8, Moreau P9, Min CK10, Pluta A11, Chng WJ12, Kaiser M13, Zweegman S14, Mateos MV15, Spencer A16, Iida S17, Morgan G18, Suryanarayan K19, Teng Z19, Skacel T19, Palumbo A20, Dash AB19, Gupta N19, Labotka R19, Rajkumar SV21; TOURMALINE-MM3 study group.
Bar D, Basso A, Fantl D, He S, Horvath N, Lee C, Rowlings P, Taylor K, Spencer A, Cochrane T, Kwok F, Ramanathan S, Agis H, Zojer N, Kentos A, Offner F, Van Droogenbroeck J, Wu KL, Maiolino A, Martinez G, Zanella K, Capra M, Araújo S, Gregora E, Hajek R, Maisnar V, Pour L, Scudla V, Spicka I, Abildgaard N, Andersen N, Jensen BA, Helleberg C, Plesner T, Salomo M, Svirskaite A, Delarue R, Moreau P, Blau I, Goldschmidt H, Schieferdecker A, Teleanu V, Munder M, Röllig C, Salwender HJ, Fuhrmann S, Weisel K, Duerig J, Zeis M, Klein S, Reimer P, Schmidt C, Scheid C, Mayer K, Hoffmann M, Sosada M, Dimopoulos A, Delimpasi S, Kyrtsonis MC, Anagnostop, Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial, «THE LANCET», 2019, 393, pp. 253 - 264 [articolo]
Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Pellegrini, Cinzia; Marangon, Miriam; Morigi, Alice; Nanni, Laura; Lolli, Ginevra; Carella, Matteo; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series, «HAEMATOLOGICA», 2019, 104, pp. e521 - e522 [articolo]Open Access
Usmani, Sz; Schjesvold, F; Oriol, A; Karlin, L; Cavo, M; Rifkin, Rm; Yimer, Ha; Leblanc, R; Takezako, N; Mccroskey, Rd; Lim, Abm; Suzuki, K; Kosugi, H; Grigoriadis, G; Avivi, I; Facon, T; Jagannath, S; Lonial, S; Ghori, Ru; Farooqui, Mzh; Marinello, P; San-Miguel, J; KEYNOTE-185 Investigators., Lim A; Grigoriadis, G; Walker, T; Nicol, A; Leblanc, R; Reece, D; Elemary, M; Boudreault Pedneault, Js; Karlin, L; Facon, T; Attal, M; Weisel, K; Engelhardt, M; Mackensen, A; Quinn, J; Avivi, I; Cohen, A; Magen-Nativ, H; Benyamini, N; Larocca, A; Takezako, N; Suzuki, K; Kosugi, H; Matsumoto, M; Iida, S; Ishikawa, T; Kondo, Y; Sunami, K; Ando, K; Teshima, T; Chou, T; Iwasaki, H; Miki, H; Matsumura, I; Onishi, Y; Izutsu, K; Kizaki, M; George, A; Blacklock, H; Simpson, D; Schjesvold, F; Waage, A; Samoilova, O; Nikitin, E; Chagorova, T; Mcdonald, A; Patel, M; Oriol Rocafiguera, A; San Miguel Izquierdo, J; Mateos, M; Streetly, M; Forsyth, P; Jackson, G; Jenkins, S; Rifkin, R; Yimer, H; Mccroskey, R;, Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 448 - 458 [articolo]
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Morio; Suzuki, Kenshi; Ribrag, Vincent; Usmani, Saad Z; Jagannath, Sundar; Ocio, Enrique M; Rodriguez-Otero, Paula; San Miguel, Jesus; Kher, Uma; Farooqui, Mohammed; Liao, Jason; Marinello, Patricia; Lonial, Sagar; KEYNOTE-183 Investigators; Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda, Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 459 - 469 [articolo]
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Morio; Suzuki, Kenshi; Ribrag, Vincent; Usmani, Saad Z; Jagannath, Sundar; Ocio, Enrique M; Rodriguez-Otero, Paula; San Miguel, Jesus; Kher, Uma; Farooqui, Mohammed; Liao, Jason; Marinello, Patricia; Lonial, Sagar; KEYNOTE-183 Investigators; Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda, Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 459 - 469 [articolo]
Richardson, Paul G; Oriol, Albert; Beksac, Meral; Liberati, Anna Marina; Galli, Monica; Schjesvold, Fredrik; Lindsay, Jindriska; Weisel, Katja; White, Darrell; Facon, Thierry; San Miguel, Jesus; Sunami, Kazutaka; O'Gorman, Peter; Sonneveld, Pieter; Robak, Pawel; Semochkin, Sergey; Schey, Steve; Yu, Xin; Doerr, Thomas; Bensmaine, Amine; Biyukov, Tsvetan; Peluso, Teresa; Zaki, Mohamed; Anderson, Kenneth; Dimopoulos, Meletios; OPTIMISMM trial investigators; Abildgaard N, Adler H, Altuntas F, Akay OM, Amin B, Anagnostopoulos A, Anderson L, Anttila P, Araujo C, Arce-Lara C, Aydin Y, Basu S, Battini R, Beeker T, Benboubker L, Ben-Yehuda D, Bladé J, Blau IW, Boccia R, Burke L, Byeff P, Cascavilla N, Cavo M, Chantry A, Charles Y, Chaudhry A, Corso A, Coyne M, De Arriba F, Delimpasi S, Desjardins P, Dhakal B, Di Bartolomeo P, Di Raimondo F, Dürig J, Engelhardt M, Escoffre-Barbe M, Esteves G, Flogegard M, Gabrail N, Gamberi B, Garrison M, Gay J, Gisslinger H, Goldschmidt H, Goncalves C, Gress, Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 20, pp. 781 - 794 [articolo]
Bringhen, S; Milan, A; D'Agostino, M; Ferri, C; Wäsch, R; Gay, F; Larocca, A; Offidani, M; Zweegman, S; Terpos, E; Goldschmidt, H; Cavo, M; Ludwig, H; Driessen, C; Auner, H W; Caers, J; Gramatzki, M; Dimopoulos, M A; Boccadoro, M; Einsele, H; Sonneveld, P; Engelhardt, M, Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension, «JOURNAL OF INTERNAL MEDICINE», 2019, 286, pp. 63 - 74 [articolo]
Solli, Vincenza; Poletti, Andrea; Martello, Marina; Pantani, Lucia; Borsi, Enrica; Termini, Rosalinda; Zamagni, Elena; Tacchetti, Paola; Mancuso, Katia; Cifarelli, Luca Nunzio; Mawulolo Agboyi, Lakpo Yaovi; marzocchi, giulia; Testoni, Nicoletta; Cavo, Michele; Terragna, Carolina, Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2019, 19, pp. e78 - e79 [abstract]
Follo, M. Y.; Pellagatti, A.; Armstrong, R. N.; Ratti, S.; Mongiorgi, S.; De Fanti, S.; Bochicchio, M. T.; Russo, D.; Gobbi, M.; Miglino, M.; Parisi, S.; Martinelli, G.; Cavo, M.; Luiselli, D.; Mccubrey, J. A.; Suh, P. -G.; Manzoli, L.; Boultwood, J.; Finelli, C.; Cocco, L., Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes, «LEUKEMIA», 2019, 33, pp. 2276 - 2290 [articolo]Open Access
Stanzani, Marta; Cricca, Monica; Sassi, Claudia; Sutto, Emanuele; DE CICCO, Gabriella; Bonifazi, Francesca; Bertuzzi, Clara; Bacci, Francesco; Paolini, Stefania; Cavo, Michele; Lewis, Russell E., Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature, «MYCOSES», 2019, 62, pp. 1100 - 1107 [articolo]
Morigi, Alice; Casadei, Beatrice; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, Spontaneous remission of follicular lymphoma, «HEMATOLOGY ONCOLOGY NEWS & ISSUES», 2019, 37, pp. 626 - 627 [articolo]
